 |
|
 |
 |

Home > Company Index > Drugs > Drugs - Generic > Barr Laboratories, Inc.
 |
Barr Laboratories, Inc. |
 |
 |
 |
NEWS FROM THE WIRES |
 |
FTSE 100 dips as telcos and banks ease, Glaxo firm Aug 20 2001 02:54 AM PDT
Merck sways doctors to prescribe generic Prozac-WSJ Aug 20 2001 02:46 AM PDT
Barr sees Q1 EPS between $1.40-$1.45 Aug 07 2001 07:19 AM PDT
Barr sees mid-2003 approval for oral contraceptive Aug 07 2001 06:27 AM PDT
Barr profits more than double on strong drug sales Aug 07 2001 05:22 AM PDT
> More WIRE STORIES about this company
PROFILE |
 |
This bar serves copycats rather than cocktails. Barr Laboratories makes about 80 generic and proprietary drugs in such areas as anti-infectives, oncology, cardiology, psychotherapeutics, and women's health. Its tamoxifen citrate, a generic version of AstraZeneca's breast cancer drug Nolvadex, accounts for about two-thirds of sales; its other top seller, warfarin sodium, is the generic equivalent of DuPont's Coumadin anticoagulant. The company seeks drugs vulnerable to patent challenges to grow its generics line; it has begun making a Prozac knockoff. Barr's proprietary drugs include its CyPat prostate cancer therapy. The company plans to buy Duramed. Former chairman Bernard Sherman owns about 40% of the company.
COMPETITION |
 |
AstraZeneca PLC (AZN)
Mylan Laboratories Inc. (MYL)
Watson Pharmaceuticals, Inc. (WPI)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: June
2000 Sales (mil.): 482.30
1-Yr. Sales Growth: 8.6%
Employees: 606
Revenue per employee: $795,874.59
KEY PEOPLE |
 |
Bruce L. Downey
CEO
William T. McKee
CFO
CONTACT INFO |
 |
2 Quaker Rd.
Pomona, NY 10970
US
Phone: 845-362-1100
Fax: 845-362-2774
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |